FR2270245A1 - Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid - Google Patents
Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acidInfo
- Publication number
- FR2270245A1 FR2270245A1 FR7410325A FR7410325A FR2270245A1 FR 2270245 A1 FR2270245 A1 FR 2270245A1 FR 7410325 A FR7410325 A FR 7410325A FR 7410325 A FR7410325 A FR 7410325A FR 2270245 A1 FR2270245 A1 FR 2270245A1
- Authority
- FR
- France
- Prior art keywords
- diamino
- methylamino
- glutamic acid
- pteridyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Abstract
Prepn. of N p-( 2,4-4-diamino-6-pteridyl)-methyl -N10-methylamino)-benzoyl - -glutamic acid, (Ie, having formula involves (1) prepn. of 2,4-diamino-6-hydroxymethyl-pteridine (II) by reacting a salt (A) of 2.4,5,6-tetraamino-pyrimidine with the bisulphite (B) of 1,3-dihydroxyacetone in aq. medium, with addn. of air, using thioalcohols as catalysts and oxidn. agents, pref. SeO2; (2) halogenating (II) to 2,4-diamino-6-halomethyl-pteridine (III), with ahalogenating agent, pref, thionyl chloride or P oxychloride, in an inert medium, in presence of a basic catalyst, pref. pyridine or Net3, and (3) condensing (III) with N p-(N-methylamino)-benzoyl -glutamic acid (C) in a buffered aq. medium. Higher yields, e.g. 10-15% and purity >95% are obtd.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7410325A FR2270245A1 (en) | 1974-03-26 | 1974-03-26 | Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7410325A FR2270245A1 (en) | 1974-03-26 | 1974-03-26 | Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2270245A1 true FR2270245A1 (en) | 1975-12-05 |
FR2270245B1 FR2270245B1 (en) | 1978-04-21 |
Family
ID=9136818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7410325A Granted FR2270245A1 (en) | 1974-03-26 | 1974-03-26 | Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2270245A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2371446A1 (en) * | 1976-11-17 | 1978-06-16 | Usa | METHOD FOR PREPARING METHOTREXATE AND NEW PRODUCT THUS OBTAINED |
-
1974
- 1974-03-26 FR FR7410325A patent/FR2270245A1/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2371446A1 (en) * | 1976-11-17 | 1978-06-16 | Usa | METHOD FOR PREPARING METHOTREXATE AND NEW PRODUCT THUS OBTAINED |
Also Published As
Publication number | Publication date |
---|---|
FR2270245B1 (en) | 1978-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES438431A1 (en) | Daunomycin analogues, their preparation and use | |
GB1374823A (en) | Triazolylbenzophenones | |
GB1417003A (en) | Stabilisation of fibrinogen | |
FR2270245A1 (en) | Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid | |
Cox et al. | A simple synthesis of sulphonyl cyanides | |
IT1058284B (en) | Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid | |
SE7411243L (en) | ||
ATE62250T1 (en) | CYTIDINE-DIPHOSPHOCHOLINE SALTS, PARTICULARLY SUITABLE FOR ORAL USE. | |
GB1444787A (en) | ||
DE3777590D1 (en) | 2,5,6,7-TETRANOR-18,18,19,19-TETRADEHYDRO-4,8-INTER-M-PHENYLENE-PGI2-DERIVATIVES. | |
FR2123632A6 (en) | Prepn of 5-azacytosines and 5-azacytidines - from bis trimethylsilyl-5-azacytosine | |
GB1311837A (en) | Indamines | |
IT975318B (en) | PHOTOSENSITIVE MATERIAL PARTICULARLY FOR PHOTOTECHNICS | |
ES464352A1 (en) | Preparation of optionally substituted phenyl- and naphthyl-alkanoic acids | |
GB1305807A (en) | ||
GB1087728A (en) | Improvements in or relating to benzoic acid derivatives | |
GB1304487A (en) | ||
FR2223025A1 (en) | N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine prepn. - by catalytically hydrogenating 1-(3,3-diphenylpropyl)-2-methyl-3-phenyl) aziridine | |
GB1359372A (en) | Preparation of 1,1,2-trimethoxyethane and o-acetic acid methyl ester | |
GB1345564A (en) | M-halo-alkenyloxy phenyl ureas their preparation and their use as selective herbicides | |
GB1369409A (en) | Process for the manufacture of 1-nitro-anthraquinone | |
GB1114107A (en) | Novel sulphonamides and a process for the manufacture thereof | |
SE7605426L (en) | PROCEDURE FOR THE PREPARATION OF CHLORCYANE | |
JPS5256194A (en) | Process for copolyesterpolyol | |
GB1500120A (en) | 1,2,3-trisubstituted cyclohexanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |